Chinese medical payment parties are the core of medical regulatory policies

In the face of high-speed medical expenses, the quickest and most convenient way is to carry out comprehensive containment. Under the system of medicine and medicine, the core goal of containment is medicine. The main path is to comprehensively adjust the hospital's core sales channel.

First of all, containment will be linked to medical insurance, which is completely different from previous reforms. For a long time, China's medical system has been a strong service provider and a weak party. Because the payer passively pays, there is no constraint on the service party, which makes it difficult to implement the reform of medical services. From the perspective of international success, the strength of the payer is the key to the success of the reform. Therefore, this reform is based on the payment side as the core to promote the fact that will contribute to specific measures. At present, from the national level, the clinical path management with the DRG model as the core is being implemented, and the medical insurance payment standard for drugs is about to be introduced, which will help the paying party's refined management ability to improve. At the same time, some areas are exploring the power to strengthen the medical insurance department. From the perspective of Fujian's measures, the establishment of the medical insurance office will bring the cross-departmental powers into one department, forming an effective comprehensive supervision. If this model is promoted to the whole country, it will be greatly improved. The regulatory power of the payer. Whether it is from short-term development or long-term trend, the medical insurance as a payer will become stronger and stronger, and will also effectively promote the substantive development of the reform.

医疗监管政策的核心

Second, drug costs are at the heart of containment. The mandatory zero-addition of drugs allows hospitals to lose the incentive to profit on drugs, because drugs are no longer a source of profit but a cost burden. At the same time, in each hospital, it is mandatory to reduce the proportion of medicines to less than 30%, increase the proportion of medical services, and make the hospital return to service. In order to allow the policy to reflect its effects in the short term, strict control of medical behavior will be the focus of future policy development. Prescription reviews and rational use of drugs will be fully rolled out, and doctors' large prescriptions and major inspections will be strictly regulated. While controlling the hospital, the pharmaceutical companies are suppressed. In addition to the traditional drug bidding reform, a two-vote reform will be implemented on the circulation channels to compress the intermediate channels. In the future, commercial distribution and agents may be separated, effectively cutting off the interest chain. Of course, there are many ways for public hospitals to circumvent this. The development of supply chain business and the opening of pharmacies outside themselves will gradually increase. Therefore, follow-up policy follow-up will be more intensive.

Male Sexual Enhancement Material

Male Sexual Enhancement ;Strengthening Yang extract

Shaanxi Zhongyi Kangjian Biotechnology Co.,Ltd , https://www.zhongyiherbs.com